NewAmsterdam Pharma Co N.V 10-K for FY2023
NewAmsterdam Pharma Co N.V. (NAMS)
10-K
2024-02-28
For: 2023-12-31
View Original
Added on
April 09, 2026
About this 10-K
NewAmsterdam Pharma Co N.V filed this 10-K on February 28, 2024, covering the fiscal year ended December 31, 2023 (FY2023).
Headline figures
Fiscal year ended December 31, 2023, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $14.09M
- down 86.3% from $102.69M a year earlier
- Net loss
- $176.94M
- compared with a net loss of $22.63M a year earlier
- Diluted EPS
- -$2.15
- compared with -$1.19 a year earlier